News

Baroreflex activation therapy improves heart failure symptoms


 

AT ACC 15

References

Simultaneously with Dr. Abraham’s presentation at ACC 15, the study manuscript was published online (JACC: Heart Failure 2015 [doi: 10.1016/j.jchf.2015.02.006]).

Dr. Abraham is a consultant to CVRx (which funded the study), as well as Novartis, St. Jude Medical, CardioMEMS, and Abbott Vascular.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Long-term DAPT offers ongoing post-MI benefit
MDedge Family Medicine
Evolocumab halved cardiovascular events in OSLER study
MDedge Family Medicine
Cardiovascular event rates similar in PCI and CABG after 5 years
MDedge Family Medicine
Guideline recommends combination therapy for smoking cessation in cancer patients
MDedge Family Medicine
Apple’s ResearchKit
MDedge Family Medicine
Novel Watchman device approved as warfarin alternative in atrial fib
MDedge Family Medicine
Poor diet hampers children’s cardiovascular health
MDedge Family Medicine
VIDEO: Long-term PARTNER 1 data tip scales toward TAVR
MDedge Family Medicine
Midlife blood pressure patterns predict CVD, mortality risk
MDedge Family Medicine
ACP: Avoid ECG, MPI cardiac screening in low-risk patients
MDedge Family Medicine